Yasuo Yoneyama

Yasuo Yoneyama

UNVERIFIED PROFILE

Are you Yasuo Yoneyama?   Register this Author

Register author
Yasuo Yoneyama

Yasuo Yoneyama

Publications by authors named "Yasuo Yoneyama"

Are you Yasuo Yoneyama?   Register this Author

19Publications

329Reads

35Profile Views

Diffusely infiltrative squamous cell carcinoma of the esophagus presenting as a case with diagnostic difficulty.

Surg Today 2013 Jul 4;43(7):794-9. Epub 2012 Nov 4.

Department of Frontier Surgery, Chiba University Graduate School, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8670, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00595-012-0400
Web Search
http://link.springer.com/10.1007/s00595-012-0400-9
Publisher Site
http://dx.doi.org/10.1007/s00595-012-0400-9DOI Listing
July 2013

[A case of recurrent rectal cancer with idiopathic thrombocytopenic purpura showing rapid progression, suggesting disseminated intravascular coagulopathy].

Gan To Kagaku Ryoho 2012 Jan;39(1):139-42

Dept. of Frontier Surgery, Graduate School of Medicine, Chiba University.

View Article

Download full-text PDF

Source
January 2012

COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma.

Ann Surg Oncol 2011 Oct 25;18(10):2946-51. Epub 2011 Mar 25.

Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-1645-zDOI Listing
October 2011

Correlation between gp96 expression and the surgical outcome in patients with esophageal squamous cell carcinoma.

Ann Surg Oncol 2011 Mar 14;18(3):832-7. Epub 2010 Sep 14.

Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-010-1128-7DOI Listing
March 2011

Postoperative lymphocyte percentage influences the long-term disease-free survival following a resection for colorectal carcinoma.

Jpn J Clin Oncol 2011 Mar 3;41(3):343-7. Epub 2011 Jan 3.

Department of Colorectal and Pelvic Surgery, National Cancer Center, Chiba-ken 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq223DOI Listing
March 2011

Oncologic outcome of intersphincteric resection for very low rectal cancer.

World J Surg 2009 Aug;33(8):1750-6

Colorectal and Pelvic Surgery Division, Department of Surgical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-009-0079-2DOI Listing
August 2009

Prognostic significance of peritoneal washing cytology in patients with potentially resectable gastric cancer.

Hepatogastroenterology 2008 Sep-Oct;55(86-87):1913-5

Department of Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.

View Article

Download full-text PDF

Source
January 2009

Role of histone deacetylase inhibitor in adenovirus-mediated p53 gene therapy in esophageal cancer.

Anticancer Res 2008 Mar-Apr;28(2A):665-71

Department of Frontier Surgery, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan.

View Article

Download full-text PDF

Source
June 2008

Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.

Oncol Rep 2007 Oct;18(4):867-71

Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.

View Article

Download full-text PDF

Source
October 2007

[Two cases treated with trastuzumab as primary chemotherapy].

Gan To Kagaku Ryoho 2007 Oct;34(10):1683-7

Dept. of Frontier Surgery, Graduate School of Medicine, Chiba University.

View Article

Download full-text PDF

Source
October 2007

Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells.

Oncol Rep 2007 Sep;18(3):585-92

Department of Frontier Surgery, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan.

View Article

Download full-text PDF

Source
September 2007

Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells.

Biochem Biophys Res Commun 2007 Mar 2;355(1):129-35. Epub 2007 Feb 2.

Department of Gene Therapy, Chiba University, Chiba, Japan; Department of Frontier Surgery, Chiba University, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.01.132DOI Listing
March 2007